CYRN / CYREN Ltd - Documents déposés auprès de la SEC, rapport annuel, procuration

CYREN Ltd
US ˙ NASDAQ
CE SYMBOLE N'EST PLUS ACTIF

Statistiques de base
LEI 529900OAC2X8QEPM8R89
CIK 1084577
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to CYREN Ltd
SEC Filings (Chronological Order)
Cette page fournit une liste complète et chronologique des documents déposés auprès de la SEC, à l'exclusion des documents relatifs à la participation que nous fournissons ailleurs.
July 25, 2023 15-12G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-26495 CYREN LTD. (Exact name of registrant as specified in its charter)

February 28, 2023 POS AM

As filed with the Securities and Exchange Commission on February 28, 2023

As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No.

February 28, 2023 POS AM

As filed with the Securities and Exchange Commission on February 28, 2023

As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No.

February 28, 2023 S-8 POS

As filed with the Securities and Exchange Commission on February 28, 2023

As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No.

February 28, 2023 POS AM

As filed with the Securities and Exchange Commission on February 28, 2023

As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No.

February 28, 2023 S-8 POS

As filed with the Securities and Exchange Commission on February 28, 2023

S-8 POS 1 ea174401-s8poscyrenltd.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. 333-223050 Registration Statement No. 333-238269 Registration Statement No. 333-267452 Registration Statement No. 333-180453 Registration Statement No. 333-174748 Registration Statement No. 333-162104 Registration Statement No. 333-151929

February 28, 2023 S-8 POS

As filed with the Securities and Exchange Commission on February 28, 2023

S-8 POS 1 ea174401-s8poscyrenltd.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. 333-223050 Registration Statement No. 333-238269 Registration Statement No. 333-267452 Registration Statement No. 333-180453 Registration Statement No. 333-174748 Registration Statement No. 333-162104 Registration Statement No. 333-151929

February 28, 2023 S-8 POS

As filed with the Securities and Exchange Commission on February 28, 2023

As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No.

February 28, 2023 S-8 POS

As filed with the Securities and Exchange Commission on February 28, 2023

As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No.

February 28, 2023 S-8 POS

As filed with the Securities and Exchange Commission on February 28, 2023

As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No.

February 28, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 26, 2023 CYREN LTD. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 26, 2023 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num

February 28, 2023 S-8 POS

As filed with the Securities and Exchange Commission on February 28, 2023

As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No.

February 28, 2023 POS AM

As filed with the Securities and Exchange Commission on February 28, 2023

As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No.

February 28, 2023 S-8 POS

As filed with the Securities and Exchange Commission on February 28, 2023

As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No.

February 28, 2023 S-8 POS

As filed with the Securities and Exchange Commission on February 28, 2023

As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No.

February 28, 2023 S-8 POS

As filed with the Securities and Exchange Commission on February 28, 2023

As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No.

February 22, 2023 EX-99.1

Cyren Announces Liquidation

Exhibit 99.1 Cyren Announces Liquidation MCLEAN, VA – February 22, 2023 / Cyren (NASDAQ:CYRN), a provider of email inbox security and threat detection solutions, today announced that, in response to its inability to secure additional sources of liquidity or consummate a going concern sale, as previously disclosed, the Board of Directors of the Company approved a plan to cease operations and commen

February 22, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 22, 2023 CYREN LTD. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 22, 2023 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num

February 22, 2023 EX-99.1

Cyren Announces Nasdaq Delisting Determination

Exhibit 99.1 Cyren Announces Nasdaq Delisting Determination MCLEAN, VA – February 22, 2023 / Cyren (NASDAQ:CYRN), a provider of email inbox security and threat detection solutions, today announced that, in response to its planned liquidation, the Company received written notice from Nasdaq, advising it that based upon Nasdaq’s review and pursuant to Listing Rule 5101, 5110(b) and IM-5101-1, Nasdaq

February 22, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Bankruptcy or Receivership, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 20, 2023 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num

February 6, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 1, 2023 CYREN LTD. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 1, 2023 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numb

February 6, 2023 EX-99.1

Cyren Announces Global Reduction in Force; Liquidity Challenges

Exhibit 99.1 Cyren Announces Global Reduction in Force; Liquidity Challenges MCLEAN, VA – February 1, 2023 / Cyren (NASDAQ:CYRN), a provider of inbox security and threat detection solutions, today announced that, in response to current market conditions and associated challenges with raising additional capital, the Company approved a plan to reduce its workforce by approximately 121 employees, rep

January 17, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 12, 2023 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numb

December 30, 2022 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 29, 2022 CYREN LTD. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 29, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num

November 14, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 14, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num

November 14, 2022 EX-99.1

Cyren Announces Third Quarter 2022 Financial Results - - - Q3 Enterprise Anti-Phishing ARR Grows 74% Year-over-Year Driven by Increased Demand

Exhibit 99.1 PRESS RELEASE Cyren Announces Third Quarter 2022 Financial Results - - - Q3 Enterprise Anti-Phishing ARR Grows 74% Year-over-Year Driven by Increased Demand McLean, VA. ? November 14, 2022 ? Cyren (NASDAQ: CYRN) today announced its third quarter 2022 financial results for the period ending September 30, 2022. Cyren reported quarterly revenues of $5.8 million for the third quarter of 2

November 14, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-2649

September 16, 2022 EX-FILING FEES

FORM S-8 (Form Type) CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Table I: Newly Issued Securities

Exhibit 107 FORM S-8 (Form Type) CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Table I: Newly Issued Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Share(3) Maximum Aggregate Offering Price(3) Fee Rate Amount of Registration Fee Equity Ordinary Shares Other 790,000 (2) $ 1.37 (3) $ 1,082,300 (3) $ 92.7

September 16, 2022 S-8

As filed with the Securities and Exchange Commission on September 16, 2022

As filed with the Securities and Exchange Commission on September 16, 2022 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CYREN LTD. (Exact name of registrant as specified in its charter) Israel Not applicable (State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identificat

September 6, 2022 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 31, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numbe

August 24, 2022 CORRESP

CYREN LTD. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561

CORRESP 1 filename1.htm CYREN LTD. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561 011–972–9–863–6888 August 24, 2022 SUBMISSION VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attn: Charli Gibbs-Tabler Re: Cyren Ltd. Registration Statement on Form S-3 Filed: July 28, 2022 File No.: 333-266392 Ladies and Gentlemen: Purs

August 22, 2022 CORRESP

* * * * *

August 22, 2022 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Officer of Technology 100 F Street, N.

August 15, 2022 EX-99.1

Cyren Announces Second Quarter 2022 Financial Results - - - Enterprise Anti-Phishing ARR Grows 87% Year-over-Year and Core Threat Detection Business Exceeds Expectations

Exhibit 99.1 PRESS RELEASE Cyren Announces Second Quarter 2022 Financial Results - - - Enterprise Anti-Phishing ARR Grows 87% Year-over-Year and Core Threat Detection Business Exceeds Expectations McLean, VA. ? August 15, 2022 ? Cyren (NASDAQ: CYRN) today announced its second quarter 2022 financial results for the period ending June 30, 2022. Cyren reported quarterly revenues of $5.8 million for t

August 15, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 15, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numbe

August 15, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO S

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-26495 CYR

August 5, 2022 EX-2.1

Sale and Purchase Agreement between Cyren Ltd. and Content Services Group GmbH

Exhibit 2.1 Executed Version Project Fortress SALE AND PURCHASE AGREEMENT between CYREN LTD. and Content Services Group GmbH Page 2 Sale and Purchase Agreement THIS AGREEMENT is made among the following parties: (1)CYREN LTD., a company organized and existing under the laws of the State of Israel with its registered office at 10 Ha-Menofim St., 5th Floor, Herzliya, Israel 4672561, and registered w

August 5, 2022 EX-99.1

CYREN LTD. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Exhibit 99.1 CYREN LTD. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS On August 1, 2022, Cyren Ltd. (the ?Company? or ?Cyren?) completed the previously announced sale of all the equity interests in its legacy secure email gateway business and wholly owned subsidiary, Cyren GmbH (the ?Transaction?) for a total purchase price of EUR 10 million, subject to customary post-closing adj

August 5, 2022 8-K

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 1, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number

August 3, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 3, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number

August 3, 2022 EX-99.1

Cyren Successfully Completes Sale of its Legacy Secure Email Gateway Business

Exhibit 99.1 PRESS RELEASE Cyren Successfully Completes Sale of its Legacy Secure Email Gateway Business McLean, VA ? August 3, 2022 / Cyren Ltd. (NASDAQ: CYRN), a provider of next-generation email protection and embedded threat detection solutions, today announced that it has completed the previously announced divestment of its legacy secure email gateway business to Content Services Group GmbH f

August 2, 2022 DEF 14A

2016 Non-Employee Director Equity Incentive Plan, as amended and restated (incorporated by reference to Appendix C to the Company’s Definitive Proxy Statement filed on August 2, 2022). †

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

July 28, 2022 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-3 (Form Type) Cyren Ltd. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Numbe

July 28, 2022 S-3

As filed with the Securities and Exchange Commission on July 28, 2022

As filed with the Securities and Exchange Commission on July 28, 2022 Registration Statement No.

July 28, 2022 EX-4.1

Form of Senior Indenture

Exhibit 4.1 CYREN Ltd. and [?] Trustee INDENTURE Dated as of [?] SENIOR DEBT SECURITIES CROSS-REFERENCE TABLE(1) ACTIVE 65770231v2 Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 313(d) 4.03 314(a) 4.

July 28, 2022 EX-4.2

Form of Subordinated Indenture

Exhibit 4.2 CYREN Ltd. And Trustee INDENTURE Dated as of SUBORDINATED DEBT SECURITIES Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 313(d) 4.03 314(a) 4.02 314(b) Inapplicable 314(c) 2.04 8.04 9.01(

July 28, 2022 EX-4.4

Form of Subordinated Note

Exhibit 4.4 Form of Subordinated Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE

July 28, 2022 EX-4.3

Form of Senior Note

Exhibit 4.3 Form of Senior Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE

July 13, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 8, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number)

July 12, 2022 PRE 14A

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

June 7, 2022 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 7, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number)

June 7, 2022 EX-99.1

Cyren Announces Divestment to Enable Focus on Strategic Growth Opportunities

Exhibit 99.1 PRESS RELEASE Cyren Announces Divestment to Enable Focus on Strategic Growth Opportunities MCLEAN, VA ? June 7, 2022 / Cyren (NASDAQ:CYRN), a provider of inbox security and threat intelligence solutions, today announced that it has entered into a definitive agreement to divest its legacy Secure Email Gateway business to Content Services Group GmbH for ?10,000,000 in cash. The purchase

May 17, 2022 EX-99.1

Cyren Announces First Quarter 2022 Financial Results - - - Enterprise Anti-Phishing ARR Grows 111% Year-over-Year as Cyren Inbox Security Momentum Continues to Build

Exhibit 99.1 PRESS RELEASE Cyren Announces First Quarter 2022 Financial Results - - - Enterprise Anti-Phishing ARR Grows 111% Year-over-Year as Cyren Inbox Security Momentum Continues to Build McLean, VA. ? May 16, 2022 ? Cyren (NASDAQ: CYRN) today announced its first quarter 2022 financial results for the period ending March 31, 2022. During the first quarter of 2022, Cyren reported quarterly rev

May 17, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 16, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number)

May 16, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000?26495 CYREN LTD. (Exact na

March 30, 2022 424B3

Cyren Ltd. Up to 6,445,895 Ordinary Shares

Filed Pursuant to Rule 424(b)(3) Registration No. 333-262926 PROSPECTUS Cyren Ltd. Up to 6,445,895 Ordinary Shares This prospectus relates to the proposed resale from time to time of up to 6,445,895 ordinary shares by the selling shareholders named in this prospectus. The shares to be sold under this prospectus consist of (i) 760,757 ordinary shares, (ii) 2,368,318 ordinary shares issuable upon th

March 29, 2022 CORRESP

cyren Ltd. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561

CORRESP 1 filename1.htm cyren Ltd. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561 011–972–9–863–6888 March 29, 2022 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Jeff Kauten Josh Shainess Re: Cyren Ltd. Registration Statement on Form S-3, as amended (File No. 333-262926) Request for Acceleration of Effectiv

March 24, 2022 EX-4.1

Description of Securities.*

Exhibit 4.1 DESCRIPTION OF SECURITIES As of March 1, 2022, the ordinary shares of Cyren Ltd. (?we,? ?us,? ?our? or the ?Company?) were the Company?s only class of securities registered under Section 12(b) of the Securities Exchange Act of 1934, as amended. The following description of our share capital is intended as a summary only and therefore is not a complete description of our share capital.

March 24, 2022 EX-10.2

2016 Non-Employee Director Equity Incentive Plan, as amended and restated.†*

Exhibit 10.2 CYREN, LTD. 2016 NON-EMPLOYEE DIRECTOR EQUITY INCENTIVE PLAN Table of Contents Page 1. Establishment, Purpose and Term of Plan 1 1.1 Establishment 1 1.2 Purpose 1 1.3 Term of Plan 1 2. Definitions and Construction 1 2.1 Definitions 1 2.2 Construction 5 3. Administration 5 3.1 Administration by the Committee 5 3.2 Administration with Respect to Insiders 5 3.3 Powers of the Committee 5

March 24, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2022 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Emplo

March 24, 2022 S-3/A

As filed with the Securities and Exchange Commission on March 24, 2022

As filed with the Securities and Exchange Commission on March 24, 2022 Registration No.

March 24, 2022 EX-10.1

2016 Equity Incentive Plan, as amended and restated.†*

Exhibit 10.1 CYREN, LTD. 2016 EQUITY INCENTIVE PLAN Table of Contents Page 1. Establishment, Purpose and Term of Plan 1 1.1 Establishment 1 1.2 Purpose 1 1.3 Term of Plan 1 2. Definitions and Construction 1 2.1 Definitions 1 2.2 Construction 6 3. Administration 6 3.1 Administration by the Committee 6 3.2 Authority of Officers 6 3.3 Administration with Respect to Insiders 6 3.4 Powers of the Commit

March 24, 2022 EX-99.1

Cyren Announces Fourth Quarter and Full Year 2021 Financial Results - - - Enterprise Anti-Phishing ARR Grows 87% Year-over-Year

Exhibit 99.1 PRESS RELEASE Cyren Announces Fourth Quarter and Full Year 2021 Financial Results - - - Enterprise Anti-Phishing ARR Grows 87% Year-over-Year McLean, VA. ? March 24, 2022 ? Cyren (NASDAQ: CYRN) today announced its fourth quarter and full year 2021 financial results for the period ending December 31, 2021. During the fourth quarter of 2021, Cyren reported quarterly revenues of $7.4 mil

March 24, 2022 CORRESP

Cooley LLP 55 Hudson Yards New York, New York 10001-2157 t: (212) 479-6000 f: (212) 479-6275 cooley.com

Eric Blanchard +1 212 479 6565 [email protected] Via EDGAR March 24, 2022 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, N.E. Washington, D.C. 20549 Attention: Jeff Kauten Josh Shainess Re: Cyren Ltd. Registration Statement on Form S-3 Filed February 23, 2022 File No. 333-262926 Dear Mr. Kauten and Mr. Shainess: On behalf of Cyren Ltd

March 24, 2022 EX-21

List of Subsidiaries of the Company.*

Exhibit 21 List of Subsidiaries of the Company Subsidiary Jurisdiction of Incorporation/Organization Ownership Cyren Inc. Delaware 100 % Cyren Iceland hf Iceland 100 % Cyren Gesellschaft mbH Germany 100 % Cyren UK Ltd. United Kingdom 100 %

March 24, 2022 EX-10.21

Executive Employment Agreement dated May 16, 2013, between Cyren Ltd. and Lior Kohavi.

Exhibit 10.21 Translated from the Hebrew Lior Kohavi Employment Agreement Made and entered into in Herzliya on May 16, 2013 Between Commtouch Software Ltd. Address: 1 Sapir Street, Herzliya (hereinafter: the ?Company?) and Name: Lior Kohavi Identity No. 024966509 Address: 7 Ela Street, Ramat Hasharon (hereinafter: the ?Employee?) Whereas The Company wishes to employ the Employee in the position of

March 24, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-26495 CYREN LTD. (Exact name of

February 25, 2022 EX-99.1

Cyren Regains Compliance with Nasdaq Listing Requirements

Exhibit 99.1 PRESS RELEASE Cyren Regains Compliance with Nasdaq Listing Requirements McLean, Va. ? February 25, 2022 ? Cyren Ltd. (Nasdaq: CYRN) today announced it received formal notification from the Listing Qualifications Staff of the Nasdaq Stock Market Inc. (?Nasdaq?) that the Company has regained compliance with Listing Rule 5550(a)(2), which requires the Company to maintain a minimum closin

February 25, 2022 8-K

Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 25, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num

February 23, 2022 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-3 (Form Type) Cyren Ltd. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Numbe

February 23, 2022 S-3

As filed with the Securities and Exchange Commission on February 23, 2022

As filed with the Securities and Exchange Commission on February 23, 2022 Registration No.

February 14, 2022 EX-4.3

Form of Placement Agent Warrant

Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

February 14, 2022 EX-99.1

Cyren Announces $12 Million Private Placement Priced At-the-Market

Exhibit 99.1 PRESS RELEASE Cyren Announces $12 Million Private Placement Priced At-the-Market McLean, Va. ? February 10, 2022 ? Cyren (Nasdaq: CYRN), today announced that it has entered into a securities purchase agreement with certain institutional and other accredited investors to raise approximately $12 million through the issuance of 3,129,075 of its ordinary shares (or ordinary share equivale

February 14, 2022 EX-4.2

Form of Pre-Funded Warrant

Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

February 14, 2022 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 10, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num

February 14, 2022 SC 13G/A

CYRN / Cyren Ltd / CVI Investments, Inc. - SC 13G/A Passive Investment

CUSIP No: M26895108 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2. (Amendment No. 1)* Cyren Ltd. (Name of Issuer) Ordinary Shares, ILS 0.15 par value per share (Title of Class of Securities) M26895108 (CUSIP Number) Dece

February 14, 2022 EX-99.2

Cyren Announces Closing of $12 Million Private Placement Priced At-the-Market

EX-99.2 8 ea155532ex99-2cyrenltd.htm PRESS RELEASE ISSUED BY CYREN LTD. ON FEBRUARY 14, 2022 Exhibit 99.2 PRESS RELEASE Cyren Announces Closing of $12 Million Private Placement Priced At-the-Market McLean, Va. – February 14, 2022 – Cyren Ltd. (Nasdaq: CYRN), today announced the closing of its previously announced private placement through asecurities purchase agreement with certain institutional a

February 14, 2022 EX-10.1

Form of Securities Purchase Agreement, dated February 10, 2022, by and among Cyren Ltd. and the purchasers named therein

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of February 10, 2022, between Cyren Ltd., an Israeli corporation (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively the ?Purchasers?). WHEREAS, subject to the terms and conditions set forth

February 14, 2022 EX-10.2

Form of Registration Rights Agreement, dated February 10, 2022, by and among Cyren Ltd. and the purchasers named therein

Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this ?Agreement?) is made and entered into as of February 10, 2022, by and between Cyren Ltd., an Israeli corporation (the ?Company?), and each of the several purchasers signatory hereto (each such purchaser, a ?Purchaser? and, collectively, the ?Purchasers?). This Agreement is made pursuant to the Securities Purchase A

February 14, 2022 EX-4.1

Form of Ordinary Warrant

Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

February 10, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 10, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num

February 9, 2022 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 7, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numb

February 9, 2022 EX-99.1

Cyren Announces Reverse Share Split

Exhibit 99.1 Press Release Cyren Announces Reverse Share Split McLean, VA ? February 8, 2022 ? Today, Cyren Ltd. (NASDAQ:CYRN), (the ?Company?) a provider of email security and threat intelligence solutions announced that it intends to effect a one-for-twenty reverse split of its ordinary shares (the "Reverse Share Split"). The Reverse Share Split will be effective as of 5:00 p.m. Eastern Time on

February 9, 2022 EX-3.2

Amended and Restated Articles of Association, as amended on February 8, 2022

Exhibit 3.2 THE COMPANIES LAW A COMPANY LIMITED BY SHARES AMENDED AND RESTATED ARTICLES OF ASSOCIATION of CYREN LTD. 1. Preliminary 1.1. Construction. In these Articles, each of the following terms shall have the respective meaning appearing next to it, if not inconsistent with the subject or context: 1.1.1. ?Articles? - These Articles of Association, as amended from time to time. 1.1.2. ?Board? -

February 7, 2022 SC 13G/A

CYRN / Cyren Ltd / Yelin Lapidot Holdings Management Ltd. - AMENDMENT NO. 8 TO SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 8)* Cyren Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.15 per share (Title of Class of Securities) M26895108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu

January 5, 2022 DEF 14A

_______________________________ SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

December 15, 2021 PRE 14A

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

December 9, 2021 EX-99.1

Cyren Announces Repayment of Convertible Notes Debt Balance reduced by 52%

Exhibit 99.1 Press Release Cyren Announces Repayment of Convertible Notes Debt Balance reduced by 52% McLean, VA ? December 9, 2021 ? Today, Cyren Ltd. (NASDAQ:CYRN), a provider of email security and threat intelligence solutions announced that it has paid in full the outstanding principal amount of $10M, along with accrued interest, on unsecured convertible notes issued in December 2018 with a ma

December 9, 2021 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 2, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numb

November 16, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 15, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000–26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num

November 16, 2021 EX-99.1

Cyren Announces Third Quarter 2021 Financial Results - - - Cyren Inbox Security Momentum Continues as Customer Transactions Increase 36% Quarter-over-Quarter

Exhibit 99.1 PRESS RELEASE Cyren Announces Third Quarter 2021 Financial Results - - - Cyren Inbox Security Momentum Continues as Customer Transactions Increase 36% Quarter-over-Quarter McLean, Va. ? November 15, 2021 ? Cyren (NASDAQ: CYRN) today announced its third quarter 2021 financial results for the period ending September 30, 2021. During the third quarter, Cyren reported quarterly revenues o

November 15, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-26495 CYREN LTD. (Exac

October 8, 2021 424B3

Cyren Ltd. 29,154,725 Ordinary Shares

Pursuant to Rule 424(b)(3) Registration No.: 333-259959 PROSPECTUS Cyren Ltd. 29,154,725 Ordinary Shares This prospectus relates to the proposed resale from time to time of up to 29,154,725 ordinary shares by the selling shareholders named in this prospectus (together with any of such shareholders? pledgees, assignees, and successors-in-interest). The shares to be sold under this prospectus consis

October 6, 2021 EX-99.1

Nasdaq Grants Cyren 180-Day Extension to Meet Minimum Bid Price Requirement

Exhibit 99.1 PRESS RELEASE Nasdaq Grants Cyren 180-Day Extension to Meet Minimum Bid Price Requirement McLean, VA ? October 6, 2021 ? Today, Cyren (NASDAQ:CYRN), a provider of email security and threat intelligence solutions, announced that the Company received written notification from the Listing Qualification Department of The NASDAQ Capital Market (?Nasdaq?) granting the Company?s request for

October 6, 2021 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 6, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numbe

October 5, 2021 CORRESP

CYREN LTD. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561

CYREN LTD. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561 011?972?9?863?6888 October 5, 2021 SUBMISSION VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attn: Jan Woo Re: Cyren Ltd. Registration Statement on Form S-3 Filed: October 1, 2021 File No.: 333-259959 Ladies and Gentlemen: Pursuant to Rule 461 under the Securit

October 1, 2021 S-3

As filed with the Securities and Exchange Commission on October 1, 2021

As filed with the Securities and Exchange Commission on October 1, 2021 Registration No.

October 1, 2021 EX-4.2

Amended and Restated Articles of Association, as amended on September 9, 2021

Exhibit 4.2 THE COMPANIES LAW A COMPANY LIMITED BY SHARES AMENDED AND RESTATED ARTICLES OF ASSOCIATION of CYREN LTD. 1. Preliminary 1.1. Construction. In these Articles, each of the following terms shall have the respective meaning appearing next to it, if not inconsistent with the subject or context: 1.1.1. ?Articles? ? These Articles of Association, as amended from time to time. 1.1.2. ?Board? ?

September 20, 2021 EX-99.1

Cyren Announces $10.2 Million Private Placement Priced at a Premium to Market

Exhibit 99.1 PRESS RELEASE Cyren Announces $10.2 Million Private Placement Priced at a Premium to Market McLean, Va. ? September 15, 2021 ? Cyren (Nasdaq: CYRN), today announced that it has entered into securities purchase agreements with certain institutional and other accredited investors to raise approximately $10.2 million through the issuance of 14,152,779 of its ordinary shares (or ordinary

September 20, 2021 EX-10.1

Form of Securities Purchase Agreement, dated September 15, 2021, between Cyren Ltd. and the purchasers named therein.

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of September 15, 2021, between Cyren Ltd., an Israeli corporation (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively the ?Purchasers?). WHEREAS, subject to the terms and conditions set fort

September 20, 2021 EX-4.1

Form of Ordinary Warrant

Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

September 20, 2021 EX-4.2

Form of Placement Agent Warrant

Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

September 20, 2021 EX-10.2

Form of Registration Rights Agreement, dated September 15, 2021, between Cyren Ltd. and the purchasers named therein.

Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this ?Agreement?) is made and entered into as of September 15, 2021, by and between Cyren Ltd., an Israeli corporation (the ?Company?), and each of the several purchasers signatory hereto (each such purchaser, a ?Purchaser? and, collectively, the ?Purchasers?). This Agreement is made pursuant to the Securities Purchase

September 20, 2021 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 15, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Nu

August 25, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2021 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Empl

August 16, 2021 EX-99.1

Cyren Announces Second Quarter 2021 Financial Results - - - Cyren Inbox Security, Anti-Phishing for the Enterprise, Achieves Record ARR Growth

Exhibit 99.1 PRESS RELEASE Cyren Announces Second Quarter 2021 Financial Results - - - Cyren Inbox Security, Anti-Phishing for the Enterprise, Achieves Record ARR Growth McLean, Va. ? August 16, 2021 ? Cyren (NASDAQ: CYRN) today announced its second quarter 2021 financial results for the period ending June 30, 2021. During the second quarter, Cyren reported quarterly revenues of $7.6 million, comp

August 16, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2021 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Empl

August 16, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-26495 CYREN LTD. (Exact nam

July 13, 2021 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) July 8, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number) (

June 3, 2021 DEF 14A

Executive Compensation Policy (incorporated by reference to Annex B to the Proxy Statement filed June 3, 2021).

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

May 18, 2021 PRE 14A

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

May 17, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2021 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000?26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employe

May 17, 2021 EX-99.1

Cyren Announces First Quarter 2021 Financial Results - - - Cyren Continues to Gain Traction in the Anti-Phishing Market with Cyren Inbox Security

EXHIBIT 99.1 PRESS RELEASE Cyren Announces First Quarter 2021 Financial Results - - - Cyren Continues to Gain Traction in the Anti-Phishing Market with Cyren Inbox Security McLean, Va. ? May 17, 2021 ? Cyren (NASDAQ: CYRN) today announced its first quarter 2021 financial results for the period ending March 31, 2021. During the first quarter, Cyren reported quarterly revenues of $8.8 million, compa

May 17, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000?26495 CYREN LTD. (Exact na

April 13, 2021 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 8, 2021 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000?26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employ

March 30, 2021 EX-4.1

Description of Securities*

Exhibit 4.1 DESCRIPTION OF SECURITIES As of December 31, 2020, the ordinary shares of Cyren Ltd. (?we,? ?us,? ?our? or the ?Company?) were the Company?s only class of securities registered under Section 12(b) of the Securities Exchange Act of 1934, as amended. The following description of our share capital is intended as a summary only and therefore is not a complete description of our share capit

March 30, 2021 10-K

Annual Report - ANNUAL REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000?26495 CYREN LTD. (Exact name of

March 30, 2021 EX-21

List of Subsidiaries of the Company.*

Exhibit 21 List of Subsidiaries of the Company Subsidiary Jurisdiction of Incorporation/Organization Ownership Cyren Inc. Delaware 100 % Cyren Iceland hf Iceland 100 % Cyren Gesellschaft mbH Germany 100 % Cyren UK Ltd. United Kingdom 100 %

February 22, 2021 EX-99.1

Cyren Announces Fourth Quarter and Full Year 2020 Financial Results - - -

EX-99.1 2 ea136191ex99-1cyrenltd.htm PRESS RELEASE OF CYREN LTD. DATED FEBRUARY 22, 2021 Exhibit 99.1 PRESS RELEASE Cyren Announces Fourth Quarter and Full Year 2020 Financial Results - - - McLean, VA. – February 22, 2021 – Cyren (NASDAQ: CYRN) today announced its fourth quarter and full year 2020 financial results for the period ending December 31, 2020. During the fourth quarter, Cyren reported

February 22, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2021 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000?26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Em

February 19, 2021 SC 13G

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2. (Amendment No. ___)* Cy

CUSIP No: M26895108 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2. (Amendment No. )* Cyren Ltd. (Name of Issuer) Ordinary Shares, ILS 0.15 par value per share (Title of Class of Securities) M26895108 (CUSIP Number) Febru

February 16, 2021 EX-10.2

Engagement Agreement, dated February 10, 2021, by and between Cyren Ltd. and H.C. Wainwright & Co, LLC

EX-10.2 5 ea135591ex10-2cyren.htm ENGAGEMENT AGREEMENT, DATED FEBRUARY 10, 2021, BY AND BETWEEN CYREN LTD. AND H.C. WAINWRIGHT & CO, LLC Exhibit 10.2 Execution Version February 10, 2021 STRICTLY CONFIDENTIAL Cyren Ltd. 10 Ha-Menofim St., 5th Floor Herzliya, Israel 4672561 Attn: Brett Jackson, Chief Executive Officer Dear Mr. Jackson: This letter agreement (this “Agreement”) constitutes the agreeme

February 16, 2021 EX-10.1

Form of Securities Purchase Agreement, dated February 11, 2021, by and among Cyren Ltd. and the purchasers named therein

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of February 11, 2021, between Cyren Ltd., an Israeli corporation (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively the ?Purchasers?). WHEREAS, subject to the terms and conditions set forth

February 16, 2021 EX-99.1

Cyren Announces $13.8 Million Registered Direct Offering of Ordinary Shares

Exhibit 99.1 Cyren Announces $13.8 Million Registered Direct Offering of Ordinary Shares McLean, VA, Feb. 11, 2021 – Cyren, Ltd. (NASDAQ: CYRN), a provider of email security and threat intelligence solutions, today announced that it has entered into securities purchase agreements with several institutional investors for the purchase and sale, in a registered direct offering, of 12,000,000 of its o

February 16, 2021 EX-4.1

Form of Placement Agent Warrant

Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

February 16, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 10, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000?26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num

February 16, 2021 424B5

CYREN LTD. 12,000,000 Ordinary Shares

Filed Pursuant to Rule 424(b)(5) Registration No. 333-233316 Prospectus Supplement to Prospectus dated August 16, 2019 CYREN LTD. 12,000,000 Ordinary Shares We are offering 12,000,000 of our ordinary shares, par value ILS 0.15 per share (the “ordinary shares”), at an offering price of $1.15 per share, directly to certain investors, referred to as “the investors.” Our ordinary shares are listed on

February 11, 2021 8-K

Results of Operations and Financial Condition - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 11, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000–26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num

February 2, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 7)* Cyren Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.15 per share (Title of Class of Securities)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 7)* Cyren Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.15 per share (Title of Class of Securities) M26895108 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu

January 27, 2021 EX-10.2

Supplemental Letter Agreement dated January 26, 2021

Exhibit 10.2 January 26, 2021 Re: Supplemental Employment Terms Mr. Kenneth Tarpey 10590 Mountain Shadow Lane Marshall, VA 20115 Dear Ken: The purpose of this letter agreement (the “Letter Agreement”) is to confirm our agreement that in the event that (i) your employment is Involuntarily Terminated by Cyren Ltd. or its successor (as applicable, the “Company”), and (ii) such termination occurs with

January 27, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2021 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File

January 27, 2021 EX-10.1

Offer Letter dated January 26, 2021

Exhibit 10.1 January 26, 2021 Mr. Kenneth Tarpey 10590 Mountain Shadow Lane Marshall, VA 20115 VIA ELECTRONIC MAIL Dear Ken, On behalf of Cyren Inc. (the “Company”), I am pleased to offer you the position of Chief Financial Officer reporting to Brett Jackson, Chief Executive Officer. Commencement Date: Provided you accept the offer contained herein by January 27, 2021 and provided the undersigned

January 27, 2021 EX-99.1

Cyren Announces Appointment of Kenneth Tarpey as Chief Financial Officer

Exhibit 99.1 PRESS RELEASE Cyren Announces Appointment of Kenneth Tarpey as Chief Financial Officer McLean, Va. – January 27, 2021 – Cyren (NASDAQ: CYRN), a provider of email security and threat intelligence solutions, today announced that Kenneth Tarpey will join the Company as Chief Financial Officer, replacing Michael Myshrall, who, after ten years with the company, is moving on to pursue other

January 12, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2021 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S.

November 16, 2020 EX-99.1

Cyren Reports Third Quarter 2020 Financial Results - - - Cyren Inbox Security continues to gain momentum supporting company’s growth strategy

Exhibit 99.1 PRESS RELEASE Cyren Reports Third Quarter 2020 Financial Results - - - Cyren Inbox Security continues to gain momentum supporting company’s growth strategy McLean, Va. – November 16, 2020 – Cyren (NASDAQ: CYRN), a provider of email security and threat intelligence solutions, today announced its third quarter 2020 financial results for the period ending September 30, 2020. “The third q

November 16, 2020 8-K

Results of Operations and Financial Condition, Financial Statements and Exhibits - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Em

November 16, 2020 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exac

August 12, 2020 10-Q

Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exact nam

August 12, 2020 EX-99.1

Cyren Reports Second Quarter 2020 Financial Results - - - Positive initial market traction with new strategy and enterprise offerings

Exhibit 99.1 PRESS RELEASE Cyren Reports Second Quarter 2020 Financial Results - - - Positive initial market traction with new strategy and enterprise offerings McLean, Va. – August 12, 2020 – Cyren (NASDAQ: CYRN), a provider of email security and threat intelligence solutions, today announced its second quarter 2020 financial results for the period ending June 30, 2020. “During the second quarter

August 12, 2020 8-K

Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Empl

August 3, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employ

June 25, 2020 DEF 14A

- PROXY STATEMENT

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

June 12, 2020 PRE 14A

- PRELIMINARY PROXY STATEMENT

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

June 1, 2020 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employe

May 26, 2020 424B3

Cyren Ltd. 16,586,396 Ordinary Shares

Pursuant to Rule 424(b)(3) Registration No. 333-238266 PROSPECTUS Cyren Ltd. 16,586,396 Ordinary Shares This prospectus relates to the proposed resale from time to time of up to 16,586,396 ordinary shares, par value ILS 0.15 per share, by the selling shareholders named herein, together with any additional selling shareholders listed in a prospectus supplement (together with any of such shareholder

May 21, 2020 CORRESP

-

CYREN LTD. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561 011–972–9–863–6888 May 21, 2020 SUBMISSION VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attn: Mr. Larry Spirgel Re: Cyren Ltd. Registration Statement on Form S-3 Filed May 14, 2020 File No. 333-238266 Ladies and Gentlemen: Pursuant to Rule 461 under the Secur

May 14, 2020 S-8

- REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on May 14, 2020 Registration No.

May 14, 2020 S-3

- REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on May 14, 2020 Registration No.

May 13, 2020 8-K

Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employe

May 13, 2020 EX-99.1

Cyren Announces First Quarter 2020 Financial Results - - - Net Loss Decreases And Company Launches New Cloud-based Anti-Phishing Product for Enterprises

Exhibit 99.1 PRESS RELEASE Cyren Announces First Quarter 2020 Financial Results - - - Net Loss Decreases And Company Launches New Cloud-based Anti-Phishing Product for Enterprises McLean, Va. – May 13, 2020 – Cyren (NASDAQ: CYRN) today announced its first quarter 2020 financial results for the period ending March 31, 2020. During the first quarter, Cyren reported quarterly revenues of $9.6 million

May 13, 2020 10-Q

Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exact na

April 30, 2020 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Emplo

March 30, 2020 EX-4.1

Exhibit 4.1

Exhibit 4.1 DESCRIPTION OF SECURITIES As of December 31, 2019, the ordinary shares of Cyren Ltd. (“we,” “us,” “our” or the “Company”) were the Company’s only class of securities registered under Section 12(b) of the Securities Exchange Act of 1934, as amended. The following description of our share capital is intended as a summary only and therefore is not a complete description of our share capit

March 30, 2020 EX-10.12

Offer Letter dated January 9, 2011, between Commtouch Ltd. and J. Michael Myshrall, as supplemented on March 2, 2020.†*

Exhibit 10.12 January 9, 2011 J. Michael Myshrall [redacted] Dear Michael, On behalf of Commtouch Inc. (“Company”), I am pleased to offer you the position of Vice President, Corporate Business Development, reporting to the CEO. Base Salary Your base salary is $16,666.66 per month, or approximately $200,000 on a yearly basis. Salary will be paid on a semi-monthly basis. Your employment shall remain

March 30, 2020 10-K

Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exact name of

March 30, 2020 EX-21

List of Subsidiaries of the Company.*

Exhibit 21 List of Subsidiaries of the Company Subsidiary Jurisdiction of Incorporation/Organization Ownership Cyren Inc. Delaware 100 % Cyren Iceland hf Iceland 100 % Cyren Gesellschaft mbH Germany 100 % Cyren UK Ltd. United Kingdom 100 %

March 30, 2020 EX-10.5

Summary of Director Compensation.

Exhibit 10.5 SUMMARY OF DIRECTOR COMPENSATION The following is a summary of the compensation terms of the non-executive directors of Cyren Ltd. (the “Company”). At the Company’s 2019 Annual Meeting of Shareholders, the Company’s shareholders approved the following compensation for its non-executive directors, to remain in effect from the shareholder approval date of July 30, 2019: 1) Annual Cash C

March 25, 2020 EX-99.1

Cyren Announces Fourth Quarter and Full Year 2019 Financial Results - - - Annual revenue increased 7% over prior year

Exhibit 99.1 PRESS RELEASE Cyren Announces Fourth Quarter and Full Year 2019 Financial Results - - - Annual revenue increased 7% over prior year McLean, Va. – March 25, 2020 – Cyren (NASDAQ: CYRN) today announced its fourth quarter and full year 2019 financial results for the period ending December 31, 2019. During the fourth quarter, Cyren reported quarterly revenues of $9.5 million, compared to

March 25, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Emplo

March 19, 2020 EX-10.1

Form of Securities Purchase Agreement, dated as of March 16, 2020, by and among Cyren Ltd. And the purchasers named therein

EX-10.1 3 ea119750ex10-1cyren.htm FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF MARCH 16, 2020, BY AND AMONG CYREN LTD. AND THE PURCHASERS NAMED THEREIN Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of March 16, 2020, between Cyren Ltd., an Israeli corporation (the “Company”), and each purchaser identified on the signature pages h

March 19, 2020 EX-10.3

Form of Subsidiary Guarantee, dated as of March 19, 2020

EX-10.3 5 ea119750ex10-3cyren.htm FORM OF SUBSIDIARY GUARANTEE, DATED AS OF MARCH 16, 2020 Exhibit 10.3 SUBSIDIARY GUARANTEE SUBSIDIARY GUARANTEE, dated as of March 19, 2020 (this “Guarantee”), made by each of the signatories hereto (together with any other entity that may become a party hereto as provided herein, the “Guarantors”), in favor of the purchasers signatory (together with their permitt

March 19, 2020 EX-10.2

Form of Registration Rights Agreement, dated as of March 16, 2020, by and among Cyren Ltd. And the purchasers named therein

EX-10.2 4 ea119750ex10-2cyren.htm FORM OF REGISTRATION RIGHTS AGREEMENT, DATED AS OF MARCH 16, 2020, BY AND AMONG CYREN LTD. AND THE PURCHASERS NAMED THEREIN Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 16, 2020, between Cyren Ltd., an Israeli corporation (the “Company”), and each of the several purchasers sig

March 19, 2020 EX-4.1

Form of 5.75% Convertible Debenture Due 2024

Exhibit 4.1 EXHIBIT A NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECT

March 19, 2020 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 19, 2020 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000–26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number

March 17, 2020 EX-99.1

Cyren Announces Private Placement of Convertible Debentures

Exhibit 99.1 PRESS RELEASE Cyren Announces Private Placement of Convertible Debentures McLean, VA – March 17, 2020 – Cyren (NASDAQ: CYRN) announced today that it has entered into purchase agreements with a select group of accredited and institutional investors for the purchase of $10.25 million aggregate principal amount of convertible debentures in a private placement. The debentures will be unse

March 17, 2020 EX-99.2

Investor Presentation

Exhibit 99.2

March 17, 2020 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 16, 2020 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000–26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number

February 10, 2020 SC 13D/A

CYRN / CYREN Ltd. / Wp Xii Investments B.v. - SC 13D/A Activist Investment

SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5) Cyren Ltd. (Name of Issuer) Ordinary Shares, nominal value NIS 0.15 per share (Title of Class of Securities) M25596202 (CUSIP Number) Robert B. Knauss General Counsel and Managing Director Warburg Pincus LLC 450 Lexington Avenue New York, New York 10017 (212

February 10, 2020 SC 13G/A

CYRN / CYREN Ltd. / Yelin Lapidot Holdings Management Ltd. - AMENDMENT NO.6 TO SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 6)* Cyren Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.15 per share (Title of Class of Securities) M26895108 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu

November 13, 2019 10-Q

CYRN / CYREN Ltd. 10-Q - Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exac

November 13, 2019 EX-99.1

Cyren Announces Third Quarter 2019 Financial Results - - - Year-to-date revenue up 9% despite slight revenue decline during quarter

Exhibit 99.1 PRESS RELEASE Cyren Announces Third Quarter 2019 Financial Results - - - Year-to-date revenue up 9% despite slight revenue decline during quarter McLean, Va. – November 13, 2019 – Cyren (NASDAQ: CYRN) today announced its third quarter 2019 financial results for the period ending September 30, 2019. During the third quarter, Cyren reported quarterly revenues of $9.5 million, compared t

November 13, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Em

November 12, 2019 SC 13D/A

CYRN / CYREN Ltd. / Wp Xii Investments B.v. - SCHEDULE 13D/A NO.4 Activist Investment

Schedule 13D/A No.4 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4) Cyren Ltd. (Name of Issuer) Ordinary Shares, nominal value NIS 0.15 per share (Title of Class of Securities) M25596202 (CUSIP Number) Robert B. Knauss General Counsel and Managing Director Warburg Pincus LLC 450 Lexington Avenue New York, New York

November 7, 2019 8-K

Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Emp

November 7, 2019 EX-99.1

Cyren Announces Closing of Rights Offering

Exhibit 99.1 PRESS RELEASE Cyren Announces Closing of Rights Offering McLean, Va. – November 7, 2019 – Cyren (NASDAQ: CYRN) announced today that its previously announced rights offering (the “Rights Offering”) closed on November 6, 2019 and generated approximately $8 million of gross proceeds. Cyren issued a total of 4,635,584 ordinary shares at $1.73 per share. This includes 4,624,277 shares issu

October 4, 2019 EX-99.3

FORM OF LETTER TO NOMINEE HOLDERS CYREN LTD. Subscription Rights to Purchase up to 7,240,808 Ordinary Shares

Exhibit 99.3 FORM OF LETTER TO NOMINEE HOLDERS CYREN LTD. Subscription Rights to Purchase up to 7,240,808 Ordinary Shares October 4, 2019 To Securities Dealers, Commercial Banks, Trust Companies and Other Nominees: This letter is being distributed by Cyren Ltd. (the “Company”) to securities dealers, commercial banks, trust companies and other nominees in connection with a distribution in a rights

October 4, 2019 8-K

Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Empl

October 4, 2019 EX-99.1

FORM OF INSTRUCTIONS AS TO USE OF CYREN LTD. SUBSCRIPTION RIGHTS CERTIFICATES CONSULT THE INFORMATION AGENT, YOUR BANK OR YOUR BROKER AS TO ANY QUESTIONS

Exhibit 99.1 FORM OF INSTRUCTIONS AS TO USE OF CYREN LTD. SUBSCRIPTION RIGHTS CERTIFICATES CONSULT THE INFORMATION AGENT, YOUR BANK OR YOUR BROKER AS TO ANY QUESTIONS The following instructions relate to a rights offering by Cyren Ltd., an Israeli company (“Company”), to the holders of record of its ordinary shares, as described in the Company’s prospectus supplement dated October 4, 2019 (the “Pr

October 4, 2019 EX-99.5

BENEFICIAL OWNER ELECTION FORM

Exhibit 99.5 BENEFICIAL OWNER ELECTION FORM The undersigned acknowledge(s) receipt of your letter and the enclosed materials relating to the grant of non-transferable rights (the “Rights”) to subscribe for and purchase up to 7,240,808 ordinary shares (“Shares”) of Cyren Ltd. (the “Company”). With respect to any instructions to exercise (or not to exercise) Rights, the undersigned acknowledges that

October 4, 2019 EX-99.2

FORM OF LETTER TO RECORD HOLDERS CYREN LTD. Subscription Rights to Purchase up to 7,240,808 Ordinary Shares

Exhibit 99.2 FORM OF LETTER TO RECORD HOLDERS CYREN LTD. Subscription Rights to Purchase up to 7,240,808 Ordinary Shares October 4, 2019 Dear Shareholder: This letter is being distributed by Cyren Ltd. (the “Company”) to all holders of record of its ordinary shares at 5:00 p.m., New York City time, on September 25, 2019 (the “Record Date”), in connection with a distribution in a rights offering (t

October 4, 2019 EX-99.7

THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE COMPANY’S PROSPECTUS SUPPLEMENT DATED OCTOBER 4, 2019 (THE “PROSPECTUS”) AND ARE INCORPORATED HEREIN BY REFERENCE. COPIES OF THE PROSPECTUS ARE AVAILABLE UPON REQUEST FROM D.F. KING

EX-99.7 9 f8k100419ex99-7cyrenltd.htm FORM OF SUBSCRIPTION RIGHTS CERTIFICATE Exhibit 99.7 RIGHTS CERTIFICATE #: NUMBER OF RIGHTS THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE COMPANY’S PROSPECTUS SUPPLEMENT DATED OCTOBER 4, 2019 (THE “PROSPECTUS”) AND ARE INCORPORATED HEREIN BY REFERENCE. COPIES OF THE PROSPECTUS ARE AVAILABLE UPON REQUEST FROM D.F. KING & CO., INC., THE IN

October 4, 2019 EX-99.8

Cyren Announces Commencement of Rights Offering

Exhibit 99.8 PRESS RELEASE Cyren Announces Commencement of Rights Offering McLean, Va. – October 4, 2019 – Cyren (NASDAQ: CYRN) (the “Company”) announced today that it has commenced the previously announced rights offering to raise gross proceeds of approximately $12.5 million (the “Rights Offering”). Under the terms of the Rights Offering, the holders of the Company’s ordinary shares as of 5:00 p

October 4, 2019 EX-99.4

FORM OF LETTER TO CLIENTS OF NOMINEE HOLDERS CYREN LTD. Subscription Rights to Purchase up to 7,240,808 Ordinary Shares

Exhibit 99.4 FORM OF LETTER TO CLIENTS OF NOMINEE HOLDERS CYREN LTD. Subscription Rights to Purchase up to 7,240,808 Ordinary Shares October 4, 2019 To Our Clients: Enclosed for your consideration is a prospectus supplement, dated October 4, 2019 to a prospectus dated August 16, 2019 (collectively, the “Prospectus”), which relates to the offering (the “Rights Offering”) of Cyren Ltd. (the “Company

October 4, 2019 EX-99.6

NOMINEE HOLDER CERTIFICATION CYREN LTD.

Exhibit 99.6 NOMINEE HOLDER CERTIFICATION CYREN LTD. The undersigned, a broker, custodian bank, trustee, depositary or other nominee holder of non-transferable rights (the “Rights”) to subscribe for and purchase up to 7,240,808 ordinary shares (“Shares”) of Cyren Ltd. (the “Company”) pursuant to the rights offering described and provided for in the Company’s prospectus supplement, dated October 4,

October 4, 2019 424B5

CYREN LTD. SUBSCRIPTION RIGHTS TO PURCHASE UP TO 7,240,808 ORDINARY SHARES

Filed Pursuant to Rule 424(b)(5) Registration No. 333- 233316 PROSPECTUS SUPPLEMENT (to Prospectus dated August 16, 2019) CYREN LTD. SUBSCRIPTION RIGHTS TO PURCHASE UP TO 7,240,808 ORDINARY SHARES We are distributing at no charge to the holders of our ordinary shares as of the close of business on September 25, 2019, which we refer to as the record date, subscription rights to purchase up to an ag

September 12, 2019 SC 13D/A

CYRN / CYREN Ltd. / Wp Xii Investments B.v. - SCHEDULE 13D/A NO.3 Activist Investment

Schedule 13D/A No.3 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3) Cyren Ltd. (Name of Issuer) Ordinary Shares, nominal value NIS 0.15 per share (Title of Class of Securities) M25596202 (CUSIP Number) Robert B. Knauss General Counsel and Managing Director Warburg Pincus LLC 450 Lexington Avenue New York, New York

September 12, 2019 EX-99.E

WP XII Investments B.V. Atrium Strawinskylaan 3051 1077 ZX Amsterdam The Netherlands

Exhibit E Exhibit E WP XII Investments B.V. Atrium Strawinskylaan 3051 1077 ZX Amsterdam The Netherlands September 11, 2019 Cyren Ltd. 10 Ha-Menofim St 5th Floor Herzliya 4672561, Israel Re: Rights Offering Commitment In connection with a contemplated Rights Offering of Cyren Ltd. (the “Company”) of up to $12.5 million to its shareholders as of the applicable record date, WP XII Investments BV (th

September 11, 2019 EX-99.1

Cyren Announces Rights Offering

Exhibit 99.1 PRESS RELEASE Cyren Announces Rights Offering McLean, Va. – September 11, 2019 – Cyren (NASDAQ: CYRN) (the “Company”) announced today that its board of directors has approved a rights offering (the “Rights Offering”) to raise proceeds of up to $12,500,000. Pursuant to the Rights Offering, each holder of ordinary shares at the close of business on September 25, 2019 (the "Record Date")

September 11, 2019 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. E

August 26, 2019 8-K/A

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file nu

August 19, 2019 CORRESP

CYRN / CYREN Ltd. CORRESP - -

Cyren Ltd. 10 Ha-Menofim St 5th Floor Herzliya 4672561, Israel August 19, 2019 Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Barbara C. Jacobs, Assistant Director Re: Cyren Ltd. Registration Statement on Form S-3 File No. 333-233316 Dear Ms. Jacobs: Cyren Ltd. (the “Company”) hereby requests acceleration of the effective date of

August 16, 2019 EX-4.3

Form of Senior Note

Exhibit 4.3 Form of Senior Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE

August 16, 2019 S-3

CYRN / CYREN Ltd. S-3 - - REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on August 16, 2019 Registration No.

August 16, 2019 EX-4.2

Form of Subordinated Indenture

EX-4.2 3 fs32019ex4-2cyrenltd.htm FORM OF SUBORDINATED INDENTURE Exhibit 4.2 CYREN Ltd. and Trustee INDENTURE Dated as of SUBORDINATED DEBT SECURITIES Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 3

August 16, 2019 EX-4.1

Form of Senior Indenture

Exhibit 4.1 CYREN Ltd. and Trustee INDENTURE Dated as of SENIOR DEBT SECURITIES CROSS-REFERENCE TABLE(1) Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 313(d) 4.03 314(a) 4.02 314(b) Inapplicable 314

August 16, 2019 EX-4.4

Form of Subordinated Note

EX-4.4 5 fs32019ex4-4cyrenltd.htm FORM OF SUBORDINATED NOTE Exhibit 4.4 Form of Subordinated Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOM

August 14, 2019 EX-99.1

Cyren Announces Second Quarter 2019 Financial Results - - - First half revenue up 15% as quarterly revenue increases 6% year-over-year

Exhibit 99.1 PRESS RELEASE Cyren Announces Second Quarter 2019 Financial Results - - - First half revenue up 15% as quarterly revenue increases 6% year-over-year McLean, Va. – August 14, 2019 – Cyren (NASDAQ: CYRN) today announced its second quarter 2019 financial results for the period ending June 30, 2019. During the second quarter, Cyren reported quarterly revenues of $9.7 million – an increase

August 14, 2019 8-K

Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2019 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File N

August 14, 2019 10-Q

Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exact nam

August 2, 2019 EX-10.1

2016 Equity Incentive Plan, as amended and restated.†

Exhibit 10.1 CYREN, LTD. 2016 EQUITY INCENTIVE PLAN 1 Table of Contents Page 1. Establishment, Purpose and Term of Plan 5 1.1 Establishment 5 1.2 Purpose 5 1.3 Term of Plan 5 2. Definitions and Construction 5 2.1 Definitions 5 2.2 Construction 10 3. Administration 10 3.1 Administration by the Committee 10 3.2 Authority of Officers 10 3.3 Administration with Respect to Insiders 10 3.4 Powers of the

August 2, 2019 EX-10.2

2016 Non-Employee Director Equity Incentive Plan, as amended and restated.†

Exhibit 10.2 CYREN, LTD. 2016 NON-EMPLOYEE DIRECTOR EQUITY INCENTIVE PLAN 1 Table of Contents Page 1. Establishment, Purpose and Term of Plan 5 1.1 Establishment 5 1.2 Purpose 5 1.3 Term of Plan 5 2. Definitions and Construction 5 2.1 Definitions 5 2.2 Construction 9 3. Administration 9 3.1 Administration by the Committee 9 3.2 Administration with Respect to Insiders 9 3.3 Powers of the Committee

August 2, 2019 EX-3.1

Amended and Restated Articles of Association of the Company, as amended on July 30, 2019.

Exhibit 3.1 THE COMPANIES LAW A COMPANY LIMITED BY SHARES AMENDED AND RESTATED ARTICLES OF ASSOCIATION of cyren LTD. 1. Preliminary 1.1. Construction. In these Articles, each of the following terms shall have the respective meaning appearing next to it, if not inconsistent with the subject or context: 1.1.1. “Articles” - These Articles of Association, as amended from time to time. 1.1.2. “Board” -

August 2, 2019 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employ

June 25, 2019 DEF 14A

definitive proxy statement

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

June 13, 2019 PRE 14A

CYRN / CYREN Ltd. PRE 14A - - PRELIMINARY PROXY STATEMENT

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

May 23, 2019 EX-99.1

Cyren Expands Executive Team Announces Chief Strategy Officer and Appoints New Chief Technology Officer

Exhibit 99.1 PRESS RELEASE Cyren Expands Executive Team Announces Chief Strategy Officer and Appoints New Chief Technology Officer McLean, VA – May 23, 2019 – Cyren (NASDAQ: CYRN), a leader in cloud security, announced today that Lior Kohavi, who has served as Cyren’s Chief Technical Officer since joining the company in 2013, has been promoted to the newly created position of Chief Strategy Office

May 23, 2019 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employe

May 15, 2019 EX-99.1

Cyren Announces First Quarter 2019 Financial Results - - - First quarter revenue increases 26% year-over-year

Exhibit 99.1 PRESS RELEASE Cyren Announces First Quarter 2019 Financial Results - - - First quarter revenue increases 26% year-over-year McLean, Va. – May 15, 2019 – Cyren (NASDAQ: CYRN) today announced its first quarter 2019 financial results for the period ending March 31, 2019. During the first quarter, Cyren reported quarterly revenues of $9.7 million – an increase of 26% over the first quarte

May 15, 2019 8-K

Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2019 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File Numb

May 15, 2019 10-Q

Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exact na

April 26, 2019 EX-10.1

Executive Employment Agreement dated April 23, 2019 between Cyren Inc., Cyren Ltd. and Brett Jackson. †

Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of the 23rd day of April, 2019 (the “Effective Date”) by and between Cyren Ltd. and Cyren Ltd.’s wholly owned U.S. subsidiary, Cyren Inc. (together, “Cyren” or “Company”) and Brett Michael Jackson, a Virginia resident (“Executive”). PRELIMINARY STATEMENTS A. The Company de

April 26, 2019 EX-99.1

Cyren Appoints Brett Jackson as New CEO Security veteran tapped to lead Cyren’s next phase of growth

Exhibit 99.1 PRESS RELEASE Cyren Appoints Brett Jackson as New CEO Security veteran tapped to lead Cyren’s next phase of growth McLean, VA – April 24, 2019 – Cyren (NASDAQ: CYRN), a leader in cloud security, announced today that Brett Jackson has been appointed by Cyren’s Board of Directors to serve as the company’s next Chief Executive Officer commencing in May. Mr. Jackson will succeed Lior Samu

April 26, 2019 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2019 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File Nu

April 18, 2019 SC 13G/A

CYRN / CYREN Ltd. / Yelin Lapidot Holdings Management Ltd. - AMENDMENT NO. 5 TO SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5)* Cyren Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.15 per share (Title of Class of Securities) M26895108 (CUSIP Number) April 5, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua

March 28, 2019 EX-10.4

Form of Notice of Grant under the Non-Employee Director 2016 Equity Incentive Plan.†

Exhibit 10.4 CYREN LTD. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (For Non-Employee Directors) Cyren Ltd. (the “Company”) has granted to the Participant an award (the “Award”) of certain units pursuant to the Cyren Ltd. 2016 Non-Employee Director Equity Incentive Plan (the “Plan”), each of which represents the right to receive on the applicable Settlement Date one (1) share of Stock, as follows: P

March 28, 2019 EX-10.3

Form of Notice of Grant under the 2016 Equity Incentive Plan.†

Exhibit 10.3 CYREN LTD. NOTICE OF GRANT Cyren Ltd. (the “Company”) has granted to the Participant an award (the “Award”) of certain units pursuant to the Cyren Ltd. 2016 Equity Incentive Plan (the “Plan”), each of which represents the right to receive on the applicable Settlement Date one (1) share of Stock, as follows: Participant: Employee ID: Date of Grant: Total Number of Units: , subject to a

March 28, 2019 EX-10.7

Form of Convertible Note.

Exhibit 10.7 THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE A

March 28, 2019 10-K

Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exact name of

March 28, 2019 EX-21

List of Subsidiaries of the Company.*

Exhibit 21 List of Subsidiaries of the Company Subsidiary Jurisdiction of Incorporation/Organization Ownership Cyren Inc. Delaware 100 % Cyren Iceland hf Iceland 100 % Cyren Gesellschaft mbH Germany 100 % Cyren UK Ltd. United Kingdom 100 %

March 28, 2019 EX-10.13

Employment Contract dated June 29, 2016 between Cyren GmbH and Atif Ahmed†

Exhibit 10.13 EMPLOYMENT CONTRACT 1. CYREN GmbH and 2. Atif Ahmed 1 Term of Appointment 1 2 Employee warranties 1 3 Duties 1 4 Place of Work 2 5 Hours of Work 2 6 Salary 2 7 Expenses 2 8 Commission Payments 3 9 Private Insurance Contributions 3 10 Car Allowance 3 11 Holidays 3 12 Incapacity 4 13 Confidential Information 4 14 Intellectual Property 5 15 Payment in Lieu of Notice 5 16 Termination wit

March 28, 2019 EX-10.12

Translation of Employment Contract dated May 16, 2013 between Commtouch Ltd. and Lior Kohavi. †*

Exhibit 10.12 Employment Agreement Made and entered into in Herzliya on May 16, 2013 Between Commtouch Software Ltd. 1 Sapir St., Herzliya (Hereinafter: the “Company”) And Name: Lior Kohavi 7 Ella St., Ramat HaSharon (Hereinafter: the “Employee”) Whereas the Company wishes to hire the Employee as CTO, all subject to and in accordance with the provisions of this agreement; The parties have therefor

March 28, 2019 EX-10.11

Offer Letter dated November 19, 2013 between Commtouch Inc. and Lior Samuelson.

Exhibit 10.11 Lior Samuelson November 19, 2013 1304 Stamford Way Reston, VA 20194 Dear Lior, On behalf of Commtouch Inc. (the “Company”) and Commtouch Software Ltd, the Israeli based parent to the Company (“CTLTD”, together with the Company, “Commtouch”), I am pleased to offer you the position of Chief Executive Officer. While your base of operations shall be in the United States and your formal e

February 20, 2019 EX-99.1

Cyren Announces CEO Transition Plan - - - Lior Samuelson will assist in CEO transition and continue as Chairman of the Board

Exhibit 99.1 PRESS RELEASE Cyren Announces CEO Transition Plan - - - Lior Samuelson will assist in CEO transition and continue as Chairman of the Board McLean, Va. – February 20, 2019 – Cyren (NASDAQ: CYRN) announced today that Lior Samuelson, Chairman and Chief Executive Officer, intends to step down as CEO after transitioning his responsibilities to a successor to be identified in the future by

February 20, 2019 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2019 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File

February 13, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2019 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File

February 13, 2019 EX-99.1

Cyren Reports Fourth Quarter and Full Year 2018 Financial Results - - - Full year 2018 revenue grew 17% while fourth quarter revenue was up 26% year-over-year

Exhibit 99.1 PRESS RELEASE Cyren Reports Fourth Quarter and Full Year 2018 Financial Results - - - Full year 2018 revenue grew 17% while fourth quarter revenue was up 26% year-over-year McLean, Va. – February 13, 2019 – Cyren (NASDAQ: CYRN) today announced its fourth quarter and full year 2018 financial results for the period ending December 31, 2018. During the fourth quarter, Cyren reported quar

January 14, 2019 SC 13G/A

CYRN / CYREN Ltd. / Yelin Lapidot Holdings Management Ltd. - AMENDMENT NO. 4 TO SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4)* Cyren Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.15 per share (Title of Class of Securities) M26895108 (CUSIP Number) January 10, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur

January 10, 2019 EX-99.1

Cyren Announces Voluntary Delisting from the Tel Aviv Stock Exchange

Exhibit 99.1 PRESS RELEASE Cyren Announces Voluntary Delisting from the Tel Aviv Stock Exchange McLean, VA – January 10, 2019 – Cyren (NASDAQ: CYRN), a leader in cloud security, today announced that it is voluntarily delisting the company’s ordinary shares from trading on the Tel Aviv Stock Exchange (TASE). Consequently, Cyren intends to apply to the TASE and request that TASE initiate the delisti

January 10, 2019 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2019 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File

November 15, 2018 EX-99.1

Cyren Announces $10 Million Note Offering - - -

Exhibit 1 PRESS RELEASE Cyren Announces $10 Million Note Offering - - - McLean, Va.

November 15, 2018 6-K

CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Off

November 14, 2018 6-K

CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Off

November 14, 2018 EX-99.1

Cyren Announces Third Quarter 2018 Financial Results - - - Quarterly revenue up 26% year-over-year

Exhibit 1 PRESS RELEASE Cyren Announces Third Quarter 2018 Financial Results - - - Quarterly revenue up 26% year-over-year McLean, Va.

October 29, 2018 EX-1

Exhibit 1

Exhibit 1 PRESS RELEASE Cyren Schedules Third Quarter 2018 Earnings Release for Wednesday, November 14, 2018 McLean, VA – October 29, 2018 – Cyren (NASDAQ: CYRN) today announced it will release its third quarter 2018 results on Wednesday, November 14, 2018 before U.

October 29, 2018 6-K

CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Offi

October 1, 2018 CORRESP

CYRN / CYREN Ltd. CORRESP

Cyren Ltd. 10 Ha-Menofim St 5th Floor Herzliya 4672561, Israel October 1, 2018 Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Matt Crispino, Staff Attorney Re: Cyren Ltd. Registration Statement on Form F-3 File No. 333-227493 Dear Mr. Crispino: Cyren Ltd. (the “Company”) hereby requests acceleration of the effective date of the a

September 26, 2018 EX-99.1

Cyren Web Security Wins Second Consecutive CyberSecurity Breakthrough Award Cyren Web Security Solution Wins “Overall Secure Web Gateway Solution of the Year” Award

Exhibit 1 PRESS RELEASE Cyren Web Security Wins Second Consecutive CyberSecurity Breakthrough Award Cyren Web Security Solution Wins “Overall Secure Web Gateway Solution of the Year” Award McLean, VA – September 26, 2018 – Cyren (NASDAQ: CYRN), a leader in cloud security, today announced that its Cyren Web Security platform was named the winner of the “Overall Secure Web Gateway Solution of the Year” award for the second consecutive year from CyberSecurity Breakthrough, an independent organization that recognizes the top companies, technologies and products in the global information security market.

September 26, 2018 6-K

CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Of

September 24, 2018 EX-4.4

Form of Subordinated Indenture

Exhibit 4.4 CYREN Ltd. and Trustee INDENTURE Dated as of SUBORDINATED DEBT SECURITIES Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 313(d) 4.03 314(a) 4.02 314(b) Inapplicable 314(c) 2.04 8.04 9.01(

September 24, 2018 EX-4.3

Form of Senior Indenture

Exhibit 4.3 CYREN Ltd. and Trustee INDENTURE Dated as of SENIOR DEBT SECURITIES CROSS-REFERENCE TABLE(1) Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 313(d) 4.03 314(a) 4.02 314(b) Inapplicable 314

September 24, 2018 F-3

CYRN / CYREN Ltd. REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on September 21, 2018 Registration No.

September 24, 2018 EX-12

Computation of Ratio of Earnings to Fixed Charges

Exhibit 12 STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES The following table contains our consolidated ratio of earnings (deficiency) to fixed charges for the periods indicated.

September 24, 2018 EX-4.6

Form of Subordinated Note

Exhibit 4.6 Form of Subordinated Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE

September 24, 2018 EX-4.2

Amended and Restated Articles of Association of the Company, as amended on August 28, 2018.

Exhibit 4.2 THE COMPANIES LAW A COMPANY LIMITED BY SHARES AMENDED AND RESTATED ARTICLES OF ASSOCIATION of cyren LTD. 1. Preliminary 1.1. Construction. In these Articles, each of the following terms shall have the respective meaning appearing next to it, if not inconsistent with the subject or context: 1.1.1. “Articles” - These Articles of Association, as amended from time to time. 1.1.2. “Board” -

September 24, 2018 EX-4.5

Form of Senior Note

Exhibit 4.5 Form of Senior Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE

September 21, 2018 EX-99.1

CYREN LTD. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2018 U.S. DOLLARS IN THOUSANDS

EX-99.1 2 f6k092118ex99-1cyren.htm UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2018 Exhibit 99.1 CYREN LTD. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2018 U.S. DOLLARS IN THOUSANDS UNAUDITED INDEX Page Condensed Consolidated Balance Sheets 2 - 3 Condensed Consolidated Statements of Operations 4 Condensed Consolidated St

September 21, 2018 EX-99.2

CYREN LTD. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS For the Six Months Ended June 30, 2018

Exhibit 99.2 CYREN LTD. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS For the Six Months Ended June 30, 2018 The following discussion and analysis should be read in conjunction with our interim condensed consolidated financial statements as of and for the six months ended June 30, 2018, appearing elsewhere in this Form 6-K, our audited consolidated financial

September 21, 2018 6-K

CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Of

September 6, 2018 6-K

CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Of

September 6, 2018 EX-99.1

Cyren Launches GoCloud Partner Program New global channel program enables partners to drive growth and revenue with industry-leading cloud security products

Exhibit 1 PRESS RELEASE Cyren Launches GoCloud Partner Program New global channel program enables partners to drive growth and revenue with industry-leading cloud security products McLean, VA – September 6, 2018 – Cyren (NASDAQ: CYRN), a leader in cloud security, today announced the launch of its GoCloud Partner Program, a new global channel program that provides resellers, managed service providers, and distributors with the opportunity to predictably grow recurring revenue streams through 100% cloud security products.

August 29, 2018 6-K

CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Offic

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista